Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
2013
639 citations
Journal Article
Field-Weighted Citation Impact:
46.19
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study | Researchclopedia
·
Dutch Cancer Society
Axel Hauschild
·
University of Lübeck
J. Thaddeus Beck
·
Highlands Oncology Group
Annie St‐Pierre
·
Novartis (Switzerland)
Faiz Niazi
·
Novartis (Switzerland)
Simon Wandel
·
Novartis (Switzerland)
Malte Peters
·
Novartis (Switzerland)
Angela Zubel
·
Novartis (Switzerland)
Reinhard Dummer
·
University Hospital of Zurich